Why the study?
What are the concomitant risk factors in patients who develop torsades de pointes associated with macrolide use?
What are the concomitant risk factors in patients who develop torsades de pointes associated with macrolide use?
Increasing age, female sex, and concomitant QT-prolonging diseases or drugs are common risk factors in patients developing torsades de pointes while on macrolides.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to heightened torsades risk in older females with comorbidities on macrolides; case reports leave open prospective risk quantification.
In this case series, we examined concomitant risk factors mentioned in reports of torsades de pointes, a rare ventricular arrhythmia, that occurred in association with administration of macrolide antimicrobials (e.g., azithromycin, clarithromycin, dirithromycin, and erythromycin). Increasing age, female sex, and concomitant diseases and drug administration believed to increase risks for torsades de pointes were commonly reported.
No takes yet. Share an insight, caveat, or question.
Shaffer et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: